Emerging Trends in Neuromodulation for Treatment of Drug-Resistant Epilepsy

Abouelleil M, Deshpande N, Ali R.

Front Pain Res (Lausanne). 2022 Mar 21;3:839463.

 https://doi.org/10.3389/fpain.2022.839463


Would you like to get a general understanding of the forefront #neuromodulation treatments for patients with drug-resistant epilepsy (#DRE)?

For today’s update, we would like to share a #review by Abouelleil et al. (Mar. 2022) that summarizes essential clinical evidence for different neuromodulation treatments for patients with DRE. This review also discusses future trends of thalamic nuclei modulation with open- or closed-loop strategies.


Previous
Previous

Efficacy of adjunctive vagus nerve stimulation in patients with Dravet syndrome: A meta-analysis of 68 patients

Next
Next

Vagus nerve stimulation in children with drug-resistant epilepsy of monogenic etiology